Featured Content

Current Topics in the Treatment of Advanced PCa

Chapter 12: Dr. Kantoff and fellow thought leaders discuss their predictions for advances in the treatment of men with prostate cancer in next five years.

Developing microRNA Biomarkers for Prostate Cancer

Short, noncoding regulatory stretches of RNA known as microRNA hold promise as prostate cancer biomarkers.

Looking to the Genome for Prostate Cancer Biomarkers

Researchers are trying to develop prostate cancer biomarkers that can predict treatment effects, to spare patients toxicities associated with unhelpful regimens.

Despite USPSTF Recommendation, PSA Screening Sticking Around

Prostate-specific antigen screening is not meaningfully less frequent than before guidelines were issued against use of the test.

Immunotherapies' Disappointing Track Record for Prostate Cancer

After a litany of failures for immunotherapies against prostate cancer, calls are mounting for approaches that combine these agents with other treatments.

Prostate Cancer Resources

Special Edition Issue

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters